Ribosomal mRNA binding site (MBS)

The ribosomal mRNA binding site is a specialized region located within the small ribosomal subunit (30S in prokaryotes and 40S in eukaryotes) that coordinates the entry and positioning of messenger RNA (mRNA) for translation (Nature, 2000, DOI: 10.1038/35030000). It forms a narrow channel through which the mRNA strand slides, allowing the decoding center to facilitate the precise pairing of mRNA codons with their corresponding transfer RNA (tRNA) anticodons (PubMed, PMID: 11514518). This site is essential for the initiation and elongation phases of protein synthesis, making it a primary target for various antimicrobial agents. Antibiotics such as aminoglycosides and tetracyclines bind to or near this site to disrupt the fidelity of translation or physically block tRNA access, leading to bacterial cell death (StatPearls, NBK541030). While highly effective, the therapeutic use of drugs targeting this site is often complicated by the emergence of resistance mechanisms, such as ribosomal RNA methylation or mutations (Microbiology Spectrum, 2018). Additionally, because human mitochondrial ribosomes are evolutionarily related to bacterial ribosomes, some drugs targeting this site can cause side effects like ototoxicity and nephrotoxicity (NIH, PubChem).

Other names

mRNA binding channel30S mRNA binding site40S mRNA binding siteDecoding centerRibosomal A-site

Inhibition of translation initiation and induction of mRNA misreading by interfering with the codon-anticodon interaction at the decoding center of the small ribosomal subunit.